Medilink Raises $50 Million to Accelerate Antibody-Drug Conjugates for Cancer

Retrieved on: 2021-03-01 19:07:30

Tags for this article:

Click the tags to see associated articles and topics

Medilink Raises $50 Million to Accelerate Antibody-Drug Conjugates for Cancer. View article details on hiswai:

Excerpt

An A1 series round was led by Apricot Capital and a series-A1 was co-led by Loyal Valley Capital and Qiming Venture Partners. The company is ...

Article found on: www.biospace.com